The injection model used in this study offers a more precise and controlled approach to AD induction, whereas transgenic AD mouse models involving mutations in APP, PS1, and other genes often involve multiple pathological processes beyond Aβ accumulation, resulting in a more complex disease state. The gene discussed is APP; the disease is Alzheimer disease.